ArticleOncotarget2020

Proteomic analysis of combined IGF1 receptor targeted therapy and chemotherapy identifies signatures associated with survival in breast cancer patients.

Tali Sinai-Livne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.